These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 7347625

  • 1. Effects of 5-hydroxytryptamine and ergotamine on human superficial temporal artery.
    Ostergaard JR, Mikkelsen E, Voldby B.
    Cephalalgia; 1981 Dec; 1(4):223-8. PubMed ID: 7347625
    [Abstract] [Full Text] [Related]

  • 2. Effects of ergotamine on isolated human vessels.
    Mikkelsen E, Pedersen OL, Ostergaard JR, Pedersen SE.
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):241-52. PubMed ID: 7305561
    [Abstract] [Full Text] [Related]

  • 3. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.
    Aellig WH.
    Eur J Clin Pharmacol; 1983 Aug; 25(6):759-62. PubMed ID: 6662174
    [Abstract] [Full Text] [Related]

  • 4. Regional differences in the responsiveness of isolated arteries from cattle, dog and man.
    Müller-Schweinitzer E, Weidmann H.
    Agents Actions; 1977 Sep; 7(3):383-9. PubMed ID: 596322
    [Abstract] [Full Text] [Related]

  • 5. Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.
    Müller-Schweinitzer E.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 292(2):113-8. PubMed ID: 940593
    [Abstract] [Full Text] [Related]

  • 6. Reduced serotonin vascular sensitivity in ergotamine abusers.
    Panconesi A, Franchi G, Del Bianco PL, Anselmi B, Andreini R, Sicuteri F.
    Cephalalgia; 1989 Dec; 9(4):259-64. PubMed ID: 2611883
    [Abstract] [Full Text] [Related]

  • 7. Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.
    Cortijo J, Martí-Cabrera M, Bernabeu E, Domènech T, Bou J, Fernández AG, Beleta J, Palacios JM, Morcillo EJ.
    Br J Pharmacol; 1997 Dec; 122(7):1455-63. PubMed ID: 9421295
    [Abstract] [Full Text] [Related]

  • 8. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE, Edvinsson L, Owman C, Svendgaard NA.
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [Abstract] [Full Text] [Related]

  • 9. Actions and interactions of ergotamine and dihydroergocristine in rat aortic strips.
    Grana E, D'Agostino G, Zonta F, Lucchelli A.
    Farmaco Sci; 1981 May; 36(5):334-43. PubMed ID: 6786918
    [Abstract] [Full Text] [Related]

  • 10. Actions of indoramin on rabbit and human vasculature in vitro.
    Black JL, Mylecharane EJ.
    Clin Exp Pharmacol Physiol; 1984 May; 11(1):27-35. PubMed ID: 6713734
    [Abstract] [Full Text] [Related]

  • 11. Vascular effects of ergot alkaloids: a study on human basilar arteries.
    Müller-Schweinitzer E.
    Gen Pharmacol; 1983 May; 14(1):95-102. PubMed ID: 6826043
    [Abstract] [Full Text] [Related]

  • 12. 5-hydroxytryptamine antagonistic effects of ICI 169,369, ICI 170,809 and methysergide in human temporal and cerebral arteries.
    Jansen I, Blackburn T, Eriksen K, Edvinsson L.
    Pharmacol Toxicol; 1991 Jan; 68(1):8-13. PubMed ID: 2008418
    [Abstract] [Full Text] [Related]

  • 13. Contractile effects of noradrenaline and 5-hydroxytryptamine in human hand veins: a pharmacological receptor characterization.
    Arner M, Högestätt ED.
    Acta Physiol Scand; 1986 Oct; 128(2):209-17. PubMed ID: 2877541
    [Abstract] [Full Text] [Related]

  • 14. Differential vasomotor action of noradrenaline, serotonin, and histamine in isolated basilar artery from rat and guinea-pig.
    Chang JY, Hardebo JE, Owman C.
    Acta Physiol Scand; 1988 Jan; 132(1):91-102. PubMed ID: 2906211
    [Abstract] [Full Text] [Related]

  • 15. Ergotamine: its use in the treatment of migraine and its complications.
    Saxena VK, De Deyn PP.
    Acta Neurol (Napoli); 1992 Apr; 14(2):140-6. PubMed ID: 1329442
    [Abstract] [Full Text] [Related]

  • 16. Early effects of tetraethylammonium chloride on the contractile properties of isolated rabbit basilar arteries.
    Young AR, Säveland H, Pickard JD, Perry S, Brandt L, Ljunggren B.
    J Cereb Blood Flow Metab; 1987 Apr; 7(2):237-47. PubMed ID: 2435745
    [Abstract] [Full Text] [Related]

  • 17. Methylergometrine antagonizes 5 HT in the temporal artery.
    Tfelt-Hansen P, Jansen I, Edvinsson L.
    Eur J Clin Pharmacol; 1987 Apr; 33(1):77-9. PubMed ID: 3691600
    [Abstract] [Full Text] [Related]

  • 18. Effects of ergotamine and dihydroergotamine on 5-hydroxytryptamine-2A receptors in the isolated rat aorta.
    Kalkman HO, Schneider F.
    Pharmacology; 1996 Dec; 53(6):351-5. PubMed ID: 9032799
    [Abstract] [Full Text] [Related]

  • 19. 5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin.
    Monopoli A, Conti A, Forlani A, Ongini E, Antona C, Biglioli P.
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():59-61. PubMed ID: 2285652
    [Abstract] [Full Text] [Related]

  • 20. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ, Curtis MJ.
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.